IP Library Granted Patent US 8,777,924
Granted Patent B2
US 8,777,924 · App. 13/692,510 · Granted Jul 15, 2014

Apparatus and method for controlling insulin infusion with state variable feedback

Inventors: Sami S. Kanderian, Jr. (Germantown, MD); Garry M. Steil (Boston, MA)
Assignee: Medtronic Minimed, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,777,924
App. No.
13/692,510
Granted
Jul 15, 2014
Kind
B2
Abstract

An infusion system, which may be a closed loop, or “semi-closed-loop”, infusion system, uses state variable feedback to control the rate at which fluid is infused into a user's body. The closed loop system includes a sensor system, a controller, and a delivery system. The “semi-closed-loop” system further includes prompts that provide indications to the user prior to fluid delivery. The sensor system includes a sensor for monitoring a condition of the user and produces a sensor signal which is representative of the user's condition. The delivery system infuses a fluid into the user at a rate dictated by the commands from the controller. The system may use three state variables, e.g., subcutaneous insulin concentration, plasma insulin concentration, and insulin effect, and corresponding gains, to calculate an additional amount of fluid to be infused with a bolus and to be removed from the basal delivery of the fluid.

Claims (20)

1. A method of infusing insulin into a body of a user, the method comprising:

delivering a basal amount of insulin to the body of the user at a predetermined basal rate;

determining at least one state variable;

determining, based on the at least one state variable, an additional amount of insulin to be delivered to the body of the user; and

reducing the basal rate by said additional amount of insulin to be delivered to the body of the user.

2. The method of claim 1 , wherein the at least one state variable is selected from the group consisting of subcutaneous insulin concentration, plasma insulin concentration, and insulin effect.

3. The method of claim 1 , wherein the determining at least one state variable includes determining subcutaneous insulin concentration, plasma insulin concentration, and insulin effect.

4. The method of claim 1 , wherein the determining the additional amount of insulin is further based on at least one gain corresponding to one of the at least one state variables.

5. The method of claim 1 , further comprising repeating, after a predetermined period of time, the determining at least one state variable, determining an additional amount of insulin to be delivered to the body of the user, and reducing the basal rate by said additional amount of insulin to be delivered to the body of the user.

6. The method of claim 1 , further including determining a bolus amount of insulin and infusing said bolus amount of insulin and said additional amount of insulin to the body of the user.

7. The method of claim 6 , wherein the bolus amount of insulin is determined based on an obtained blood glucose concentration of the user.

8. The method of claim 7 , wherein the determining the bolus amount of insulin includes:

generating a controller input based on the blood glucose concentration;

generating commands by a proportional plus, integral plus, derivative (PID) controller from the controller input; and

determining, based on the commands from the PID controller, the bolus amount of insulin to be delivered to the body of the user.

9. The method of claim 8 , wherein the determining a bolus amount of insulin to be delivered to the body of the user is further based on at least one preset PID controller gain selected such that the commands generated by the PID controller cause insulin to be infused into the body of the user in response to a glucose concentration at a rate substantially equal to the rate that beta cells would release insulin in an individual with a healthy normally functioning pancreas.

10. The method of claim 9 , wherein the at least one preset controller gain is selected by a method that includes measuring an insulin response of at least one individual with a healthy normally functioning pancreas and calculating the at least one controller gain that causes the commands to substantially match the insulin response of the at least one individual.

11. The method of claim 7 , wherein the at least one state variable is selected from the group consisting of subcutaneous insulin concentration, plasma insulin concentration, and insulin effect, and wherein the determining the additional amount of insulin is further based on at least one gain corresponding to one of the at least one state variables.

12. The method of claim 6 , further including providing a prompt to indicate that the bolus amount of insulin has been determined and receiving an input to indicate that the bolus amount of insulin should be infused to the user.

13. The method of claim 6 , further comprising repeating, after a predetermined period of time, the determining at least one state variable, determining the additional amount of insulin to be delivered to the body of the user, infusing the determined bolus amount of insulin and the determined additional amount of insulin to the body of the user, and reducing the basal rate by said additional amount of insulin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2012
From: KANDERIAN, SAMI S., JR.; STEIL, GARRY M.
To: MEDTRONIC MINIMED, INC.
Reel/Frame 029394/0014 →
Continuity (7)
Continuation 12855555 · Aug 12, 2010
Continuation 11644526 · Dec 22, 2006
Continuation In Part 10816021 · Mar 31, 2004
Continuation In Part 09586175 · Jun 1, 2000
Provisional Application 60137601 · Jun 3, 1999
Provisional Application 60162255 · Oct 29, 1999
Related Publication 20130158503A1 · Jun 20, 2013